Enantioselective biocatalytic oxidative desymmetrization of substituted pyrrolidines

Angewandte Chemie - International Edition

Volumn 49, Issue 12, 2010, Pages 2182-2184

  Köhler, Valentin ^a   Bailey, Kevin R ^a   Znabet, Anass ^a   Raftery, James ^a   Helliwell, Madeleine ^a   Turner, Nicholas J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Asymmetric synthesis; Biocatalysis; Imines; Oxidation

Indexed keywords

ASYMMETRIC SYNTHESIS; BIOCATALYSIS; CHEMICAL EQUATIONS; ENANTIOSELECTIVE; GUANIDINE DERIVATIVE; MEDICINAL CHEMISTRY; MODULAR ASSEMBLY; MOLECULAR COMPLEXITY; OXIDATIVE DESYMMETRIZATION; POTENTIAL APPLICATIONS; PYRROLIDINES; RADICAL SYNTHESIS;

ELECTRON TRANSITIONS; NITROGEN COMPOUNDS; OXIDATION;

SYNTHESIS (CHEMICAL);

AMINE OXIDASE (FLAVIN CONTAINING); PYRROLIDINE DERIVATIVE;

ARTICLE; ASPERGILLUS NIGER; BIOCATALYSIS; CHEMISTRY; ENZYMOLOGY; METABOLISM; OXIDATION REDUCTION REACTION; STEREOISOMERISM;

ASPERGILLUS NIGER; BIOCATALYSIS; MONOAMINE OXIDASE; OXIDATION-REDUCTION; PYRROLIDINES; STEREOISOMERISM;

EID: 77949355247     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.200906655     Document Type: Article

References (26)

1. a) K. R. Campos, Chem. Soc. Rev. 2007, 36, 1069-1084;
2. b) C.-J. Li, Acc. Chem. Res. 2009, 42, 335-344;
3. c) I. Prochnow, R. Kubiak, O. N. Frey, R. Beckhaus, S. Doye, ChemCatChem 2009, 1, 162-172.
4. a) R. Kubiak, I. Prochnow, S. Doye, Angew. Chem. 2009, 121, 1173-1176;
5. Angew. Chem. Int. Ed. 2009, 48, 1153-1156;
6. b) S.-i. Murahashi, T. Nakae, H. Terai, N. Komiya, J. Am. Chem. Soc. 2008, 130, 11005-11012;
7. c) M. North, Angew. Chem. 2004, 116, 4218-4220;
8. Angew. Chem. Int. Ed. 2004, 43, 4126-4128;
9. d) I. Ibrahem, J. S. M. Samec, J. E. Bäckvall, A. Córdova, Tetrahedron Lett. 2005, 46, 3965-3968;
10. e) H. Li, Z. He, X. Guo, W. Li, X. Zhao, Z. Li, Org. Lett. 2009, 11, 4176-4179.
11. T. Punniyamurthy, T. Katsuki, Tetrahedron 1999, 55, 9439-9454.
12. a) N. J. Turner, Nat. Chem. Biol. 2009, 5, 567-573;
13. b) C. J. Dunsmore, R. Carr, T. Fleming, N. J. Turner, J. Am. Chem. Soc. 2006, 128, 2224-2225;
14. c) for a recent review on biocatalytic routes to optically active amines see: M. Höhne, U. T. Bornscheuer, ChemCatChem 2009, 1, 42-51.
15. a) D. A. Wood, R. F. Mason, J. A. Day, R. J. G. Searle (Shell Internationale Research Maatschappij B.V.), EP0010799, 1980;
16. 1-pyrrolines see: M.-G. A. Shvekhgeimer, Chem. Heterocycl. Compd. 2003, 39, 405-448 (engl, transl, of Khim. Geterotsikl. Soedin.).
17. a) A dimeric structure of 12 has been reported previously based on mass spectrometry and NMR spectroscopy results: M. Elkhatib, L. Peyrot, J. P. Scharff, H. Delalu, Int. J. Chem. Kinet. 1998, 30, 129-136.
18. 1-pyrroline see: b) H. Poisel, Monatsh. Chem. 1978, 109, 925-928;
19. c) J. D. Baker, R. R. Heath, J. G. Millar, J. Chem. Ecol. 1992, 18, 1595-1602;
20. d) C. Struve, C. Christophersen, Heterocycles 2003, 60, 1907-1914;
21. 3, single enantiomer] contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data- request/cif.
22. M. S. Sigman, E. N. Jacobsen, J. Am. Chem. Soc. 1998, 120, 5315-5316.
23. a) P. Revill, N. Serradell, J. Bolós, E. Rosa, Drugs Future 2007, 32, 788-798;
24. b) G. J. Tanoury, M. Chen, J. E. Cochran (Vertex Pharmaceuticals Inc.), WO2007022459, 2007.
25. a) F. G. Njoroge, K. X. Chen, N.-Y. Shih, J. J. Piwinski, Acc. Chem. Res. 2008, 41, 50-59;
26. b) G. Wu, F. X. Chen, P. Rashatasakhon, J. M. Eckert, G. S. Wong, H. C. Lee, N. C. Erickson, J. A. Vance, P. C. Nirchio, J. Weber, J.-S. D. Tsai, Z. Nanfei (Schering Corporation), WO2007075790, 2007.